Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to Ophthalmology Times Europe.
Click here to unsubscribe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Ocular implant obtains funding
Timolol treats myopic regression
Phaco causes ruptures
UK Vision Strategy deadline
 
 
Survey

Would you consider timolol as a treatment for myopic regression?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.


November 7, 2012
Ocular implant project receives €1.4 million
BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan. More...
Timolol treats myopic regression
Timolol is successful in treating myopic regression after LASIK and lasts for at least six months. More...
Product Profile
Oertli Instrumente AG
OertliKatalyst — Precision at the retina on the AAO 2012
Oertli Instruments, based in Berneck Switzerland, will be displaying its new retina instruments at the American Academy of Ophthalmology (AAO).
Read more:
Event Profile

Haag-Streit Innovation Event at AAO
Sunday November 11, 2012
Chicago, IL
Discover the new perimeter during annual meeting of the AAO. It will be the launch event for the world's first color monitor based perimeter with Pulsar for early glaucoma detection and standard White/White perimetry for follow-up.
Read more:

Phaco linked to posterior capsule rupture
Phacoemulsification is linked to a higher rate of posterior capsule rupture in vitrectomized eyes, compared to combined vitrectomy and cataract surgery. More...
UK Vision Strategy consultation deadline
The UK Vision Strategy consultation is due to close on 16 November 2012. More...